Therapeutic HPV vaccine may improve outcomes in advanced cervical cancer
(American Association for the Advancement of Science) Combining a therapeutic vaccine for human papilloma virus (HPV) with two standard chemotherapy drugs may extend survival in patients with advanced, recurrent cervical cancer, according to a phase 1/2 trial involving 77 patients.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Chemotherapy | Human Papillomavirus (HPV) | Science | Vaccines